Local field study on the effectiveness and safety of milbemycin oxime and lotilaner (Credelio<sup>®</sup> Plus) against canine gastrointestinal nematodes in the Republic of Korea. [PDF]
Lee S +5 more
europepmc +1 more source
The <i>Demodex</i> Expert Panel on Treatment and Eyelid Health (DEPTH) Consensus Regarding the Preferred Treatment for <i>Demodex</i> Blepharitis. [PDF]
Donnenfeld E +14 more
europepmc +1 more source
Pharmacotherapy of <i>Demodex</i>-Associated Blepharitis: Current Trends and Future Perspectives. [PDF]
Czępińska-Myszura A +2 more
europepmc +1 more source
<i>Demodex</i> blepharitis treatment with a selenium sulfide-containing ointment: a case report. [PDF]
Alster Y, Rafaeli O, Bosworth C.
europepmc +1 more source
Discovery of mCMV280: An Oral Ectoparasiticide in the Isoxazoline Class with Reduced Mammalian Brain Exposure. [PDF]
McComic SE +18 more
europepmc +1 more source
Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in homozygous MDR1-mutant collie dogs. [PDF]
Riggs KL, Wang X, Wiseman S.
europepmc +1 more source
Safety of Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) in dogs infected with adult heartworms (Dirofilaria immitis). [PDF]
Riggs KL, Haney D, Wiseman S.
europepmc +1 more source
Efficacy of a novel chewable tablet (Credelio Quattro™) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of hookworm infections in dogs. [PDF]
Charles S +8 more
europepmc +1 more source
Multidisciplinary perspectives in Demodex blepharitis: A new view of treatment from clinical, payer, and patient perspectives. [PDF]
Page MR.
europepmc +1 more source
Lotilaner ophthalmic solution 0.25% in Demodex blepharitis: a profile of its use
openaire +1 more source

